Mike Grey

Mike Grey Email and Phone Number

Venture Partner @ Pappas Ventures
Park City, UT, US
About Mike Grey

Experienced biotech CEO and board member. Current board member at Mirum, Reneo, Spruce, Sorriso, Plexium and Horizon Therapeutics.

Mike Grey's Current Company Details
Pappas Ventures

Pappas Ventures

View
Venture Partner
Park City, UT, US
Employees:
29
Mike Grey Work Experience Details
  • Pappas Ventures
    Venture Partner
    Pappas Ventures
    Park City, Ut, Us
  • Sorriso Pharmaceuticals
    Chairman
    Sorriso Pharmaceuticals May 2021 - Present
    San Diego, Ca, Us
  • Plexium
    Executive Chairman
    Plexium Sep 2020 - Present
    San Diego, California, Us
  • Mirum Pharmaceuticals, Inc.
    Chairman
    Mirum Pharmaceuticals, Inc. May 2018 - Present
    Foster City, Ca, Us
  • Spruce Biosciences
    Executive Chairman
    Spruce Biosciences Mar 2017 - Present
    South San Francisco, California, Us
  • Reneo Pharmaceuticals
    Executive Chairman
    Reneo Pharmaceuticals Sep 2014 - Present
    Irvine, California, Us
  • Pappas Ventures
    Venture Partner
    Pappas Ventures Jan 2010 - Present
    Durham, North Carolina, Us
    Founded in 1994, Pappas Ventures invests exclusively in the life sciences sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. Pappas Ventures has more than $350 million in capital under management, and has guided the launch and/or development of more than 50 life sciences companies, including Cerexa (acquired by Forest Laboratories), Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Syntonix (acquired by Biogen IDEC), NuVasive (IPO), and Arena Pharmaceuticals (IPO).
  • Amplyx Pharmaceuticals, Inc.
    Executive Chairman
    Amplyx Pharmaceuticals, Inc. Oct 2015 - Apr 2021
    Amplyx is developing a novel anti-fungal agent for the treatment of invasive fungal infections.
  • Ziarco Group Limited
    Executive Chairman
    Ziarco Group Limited Nov 2014 - Jan 2017
  • Lumena Pharmaceuticals Inc.
    President & Ceo
    Lumena Pharmaceuticals Inc. Feb 2011 - Jun 2014
    Lumena Pharmaceuticals, a privately-held biotechnology company since 2011, developing treatments for liver diseases was acquired by Shire for $260 million upfront and significant milestone payments.
  • Auspex Pharmaceuticals
    Ceo
    Auspex Pharmaceuticals Jan 2009 - Sep 2009
  • Sgx Pharmaceuticals
    Ceo
    Sgx Pharmaceuticals 2001 - 2008
    Us
  • Sgx
    Ceo
    Sgx 2001 - 2008
  • Trega Biosciences
    Ceo
    Trega Biosciences Jan 1999 - May 2001
  • Biochem Therapeutic
    President
    Biochem Therapeutic 1994 - 1998
  • Biochem Pharma
    President, Biochem Therapeutics
    Biochem Pharma 1994 - 1998
  • Glaxo
    Vp, Corporate Development
    Glaxo Aug 1974 - Dec 1993

Frequently Asked Questions about Mike Grey

What company does Mike Grey work for?

Mike Grey works for Pappas Ventures

What is Mike Grey's role at the current company?

Mike Grey's current role is Venture Partner.

What is Mike Grey's email address?

Mike Grey's email address is mg****@****lyx.com

What is Mike Grey's direct phone number?

Mike Grey's direct phone number is +191999*****

Who are Mike Grey's colleagues?

Mike Grey's colleagues are Phill Undefined, Barry Myers, Carolyn Cooke, Lisa Dreyer, Jeff Collins, Gerhard Schlosser, Lelia Thomas.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.